$EYPT News Article - EyePoint Pharmaceuticals and
Post# of 79
(Total Views: 937)
Posted On: 01/27/2020 11:05:42 AM
$EYPT News Article - EyePoint Pharmaceuticals and Ocumension Therapeutics Sign Exclusive License Agreement to Develop and Commercialize DEXYCU for Post-operative Inflammation in Mainland China, Hong Kong, Macau and Taiwan https://marketwirenews.com/news-releases/eyep...90291.html
(0)
(0)EyePoint Pharmaceuticals Inc. (EYPT) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼